Table 2.
Univariable and multivariable Cox regression analysis for sST2 as predictor of 1-year cardiac mortality and need for re-hospitalization in patients with heart failure.
| Variables | Univariable |
Multivariable |
||
|---|---|---|---|---|
| HR (95% CI) | p-value | HR (95% CI) | p-value | |
| Age (years) | 1.032 (0.997–1.067) | 0.070 | 1.028 (0.978–1.081) | 0.283 |
| Male gender | 0.646 (0.323–1.292) | 0.217 | ||
| Body mass index | 0.920 (0.840–1.010) | 0.076 | 0.937 (0.847–1.038) | 0.212 |
| Hypertension | 0.613 (0.300–1.252) | 0.179 | ||
| Diabetes | 0.467 (0.194–1.122) | 0.089 | 0.818 (0.318–2.100) | 0.676 |
| Dyslipidemia | 0.349 (0.169−0.725) | 0.005 | 0.905 (0.402–2.038) | 0.810 |
| History of CAD | 0.742 (0.379–1.453) | 0.384 | ||
| History of CVD | 0.784 (0.277–2.220) | 0.646 | ||
| Ischemic aetiology of HF | 0.501 (0.065–3.837) | 0.505 | ||
| Current smoking | 0.549 (0.280–1.077) | 0.081 | 0.596 (0.224–1.583) | 0.299 |
| Alcoholism | 0.540 (0.274–1.065) | 0.075 | 0.616 (0.214–1.776) | 0.370 |
| NYHA functional class | 3.336 (1.828–6.08) | 0.000 | 1.512 (0.717–3.189) | 0.004 |
| ACE-I/ARB | 0.335 (0.170–0.661) | 0.002 | 0.335 (.155−0.723) | 0.005 |
| β-blockers | 0.180 (0.092–0.351) | 0.000 | 0.325 (0.156–0.680) | 0.003 |
| MRA | 1.228 (0.538–2.806) | 0.626 | ||
| Creatinine clearance | 0.993 (0.980–1.007) | 0.338 | ||
| sST2, ng/ml | 2.810 (1.997–3.996) | 0.000 | 2.046 (1.246–3.358) | 0.005 |
Variables were included in multivariable analysis (p < 0.1); The logarithm function of sST2 was used in the analysis. ACE-I – angiotensin converting enzyme inhibitor; ARB – Angiotensinogen receptor blocker; CAD- coronary artery disease; CVD- cerebrovascular disease CI – confidence interval; HR- hazard ratio; NYHA – New York Heart Association.